Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02509377 · ClinicalTrials.gov registry record · NA
Fetal Myelomeningocele Repair With Maternal BMI Between 35.0 and 40.0
A NA study, sponsored by St. Louis University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT02509377 is a NA study that was terminated before completion, run by St. Louis University. The registered enrollment target is 1 participants.
The verdict
NCT02509377, a NA study, was terminated before completion, sponsored by St. Louis University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
Inclusion and exclusion criteria for fetal repair of MMC was established by the Management of Myelomeningocele Study (MOMS Trial) and these criteria are the standard of care throughout the United States. These criteria state exclusion for hypertension and diabetes which are known co-morbidities for obesity. Investigators plan to expand one exclusion criteria for open fetal repair surgery. Currently, an exclusion factor is a maternal BMI of 35.0 and greater.Investigators will maintain all other inclusion and exclusion criteria (including excluding for hypertension and diabetes) with the exception of expanding the BMI to include mothers with a BMI of 35.0 to 40.0. Co-morbidities of the research group will be compared to the comorbidities of the mothers published in the MOMS trial.
Interventions
- PROCEDURE Open Fetal Repair of Myelomeningocele
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2015-07 |
| Est. Completion | 2017-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02509377
The ClinicalTrials.gov registry entry for NCT02509377 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Louis University, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Open Fetal Repair of Myelomeningocele is the first listed.
NCT02509377 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02509377 about?
NCT02509377 is a clinical study titled "Fetal Myelomeningocele Repair With Maternal BMI Between 35.0 and 40.0". Inclusion and exclusion criteria for fetal repair of MMC was established by the Management of Myelomeningocele Study (MOMS Trial) and these criteria are the standard of care throughout the United States. These criteria state exclusion for hypertension and diabetes which are known co-morbidities for ...
What is the current status of trial NCT02509377?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2015-07. Estimated completion is 2017-05.
What interventions are being tested in trial NCT02509377?
The interventions under investigation include: Open Fetal Repair of Myelomeningocele (PROCEDURE).
Who is sponsoring clinical trial NCT02509377?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.